 | Up a level |
Corbacioglu, S., Lode, H., Escherich, G., Grigull, L., Hundsdoerfer, P., Steinbach, D., Schilling, F., Fruehwald, M., Greil, J., Gruhn, B., Ladenstein, R., Roessig, C. and Thorsten, S. (2016). RIST-RNB-2011: A Prospective Randomized Multicenter Trial of a Molecularly Targeted Multimodal Strategy for Patients with Relapsed and Refractory Neuroblastoma: An Update of the Ongoing Trial. Pediatr. Blood Cancer, 63. S. S209 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017
Eggert, A., Schramm, A., Koester, J., Assenov, Y., Kristina, A., Engesser, A., Kahlert, Y., Theissen, J., Hero, B., Roels, F., Peifer, M., Astrahantseff, K., Depreter, K., Lode, H., Speleman, F., Schmezer, P., Westermann, F., Rahmann, S., Fischer, M. and Schulte, J. (2015). INTEGRATED GENOMIC ANALYSIS IDENTIFIES SPECIFIC ALTERATIONS AND ACTIVATION OF YAP IN RELAPSED NEUROBLASTOMA. Pediatr. Blood Cancer, 62. S. S145 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017
Hero, B., Simon, T., Lode, H., Eggert, A. and Berthold, F. (2017). Feasibility and Toxicity of Busulfan and Melphalan Conditioning Regimen in the Context of the German Induction Chemotherapy. Pediatr. Blood Cancer, 64. S. S34 - 2. HOBOKEN: WILEY. ISSN 1545-5017